Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion.

Borchiellini D, Gravis G, Gross E, Hannoun-Levi JM, Berdah JF, Chapet O, Chebbah M, Le Clanche S, Descotes JL, Ruffion A, Maillet D, Pignot G

Open source

DOI: 10.1016/j.fjurol.2025.102998
Published: 2025 Dec
Container: The French journal of urology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.fjurol.2025.102998,
  title = {Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion.},
  author = {Borchiellini D and Gravis G and Gross E and Hannoun-Levi JM and Berdah JF and Chapet O and Chebbah M and Le Clanche S and Descotes JL and Ruffion A and Maillet D and Pignot G},
  year = {2025},
  journal = {The French journal of urology},
  doi = {10.1016/j.fjurol.2025.102998},
  url = {https://doi.org/10.1016/j.fjurol.2025.102998}
}

RIS

TY  - JOUR
TI  - Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion.
AU  - Borchiellini D
AU  - Gravis G
AU  - Gross E
AU  - Hannoun-Levi JM
AU  - Berdah JF
AU  - Chapet O
AU  - Chebbah M
AU  - Le Clanche S
AU  - Descotes JL
AU  - Ruffion A
AU  - Maillet D
AU  - Pignot G
PY  - 2025
JO  - The French journal of urology
DO  - 10.1016/j.fjurol.2025.102998
UR  - https://doi.org/10.1016/j.fjurol.2025.102998
ER  -

APA

D, B., G, G., E, G., JM, H., JF, B., O, C., M, C., S, L. C., JL, D., A, R., D, M., & G, P. (2025). Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion.. The French journal of urology. https://doi.org/10.1016/j.fjurol.2025.102998

Source records

pubmed · retrieved 2026-09-27T00:22:27.719Z
europe-pmc · retrieved 2026-09-27T00:22:27.734Z